Sophocarpine Displays Anti-Inflammatory Effect Via Inhibiting TLR4 and TLR4 Downstream Pathways on LPS-induced Mastitis in the Mammary Gland of Mice

Dehai Wang,Nian-nian Xu,Zhenbiao Zhang,Shicheng Yang,Changwei Qiu,Chengye Li,Ganzhen Deng,Mengyao Guo
DOI: https://doi.org/10.1016/j.intimp.2016.03.026
IF: 5.714
2016-01-01
International Immunopharmacology
Abstract:Mastitis is defined as the inflammation of the mammary gland. LPS, which is widely used to induce mastitis models for the study of this disease, triggers similar inflammation as Escherichia coli. Sophocarpine, isolated from Sophora alopecuroides L., exhibits multiple biological properties. The aim of the present study was to determine the anti-inflammatory effect and mechanism of action of sophocarpine on mastitis within an LPS-induced mouse model. ELISA and western blotting were performed to detect protein levels. The qPCR was performed to detect mRNA levels. The ELISA and qRT-PCR results showed that sophocarpine inhibited the expression of TNF-α, IL-1β and IL-6 in a dose-dependent manner. However, sophocarpine suppressed TLR4 expression. Further study showed that sophocarpine could suppress the phosphorylation of IκBα, p65 and p38. These results confirm that sophocarpine played an anti-inflammatory role in LPS-induced mastitis by regulating TLR4 and the NF-κB and MAPK signaling pathways in mammary gland tissues. Therefore, sophocarpine may be a potential therapeutic drug for the treatment of mastitis.
What problem does this paper attempt to address?